Registered outcomes55

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 20 of 55

List	Outcome	Time frame	Description
Primary	Pregnancy prolongation	From randomisation to delivery, measured in days and hours, up to 105 days	Length of pregnancy from diagnosis of preeclampsia to delivery
Secondary	Time for neonatal care	From birth to discharge from neonatal care, measured in days and hours, up to 126 days	Time for neonatal care from birth to discharge
Secondary	Neonatal birth weight	At birth	Birth wight measured in grams
Other	Occurrence of maternal death	Registered from inclusion to two month post partum	Occurrence of maternal death
Other	Occurrence of Eclampsia	Registered from inclusion to two month post partum	Occurrence of Eclampsia
Other	Occurrence of Cerebral vascular event	Registered from inclusion to two month post partum	Occurrence of Cerebral vascular event
Other	Occurrence of posterior reversible encephalopathy syndrome	Registered from inclusion to two month post partum	Occurrence of posterior reversible encephalopathy syndrome
Other	Occurrence of pulmonary edema	Registered from inclusion to two month post partum	Occurrence of pulmonary edema
Other	Occurrence of left ventricular failure	Registered from inclusion to two month post partum	Occurrence of left ventricular failure
Other	Occurrence of renal dialysis	Registered from inclusion to two month post partum	Occurrence of renal dialysis
Other	Occurrence of renal failure	Registered from inclusion to two month post partum	Occurrence of renal failure:≥ 90 µmol/L or no urinary output for 6 hours
Other	Occurrence of elevated liver transaminases	Registered from inclusion to two month post partum	Occurrence of elevated liver transaminases: ALT or AST ≥ 2 times highest normal value (ALAT \>1.5 µkat/L and ASAT \> 1.2 µkat/L)
Other	Occurrence of HELLP syndrome	Registered from inclusion to two month post partum	Occurrence of HELLP (Haemolysis, elevated liver enzymes and low platelets) syndrome
Other	Occurrence of thrombocytopenia	Registered from inclusion to two month post partum	Occurrence of thrombocytopenia (platelets \<100 X 109/L)
Other	Occurrence of liver haematoma or rupture	Registered from inclusion to two month post partum	Occurrence of liver haematoma or rupture
Other	Occurrence of admission to an intensive care unit	Registered from inclusion to two month post partum	Occurrence of admission to an intensive care unit
Other	Occurrence of severe hypertension	Registered from inclusion to two month post partum	Occurrence of severe hypertension (BP\>160/110 mm Hg)
Other	Occurrence of disseminated intravascular coagulation	Registered from inclusion to two month post partum	Occurrence of disseminated intravascular coagulation
Other	Occurrence of caesarean section	At birth	Occurrence of caesarean section
Other	Occurrence of major postpartum hemorrhage	At birth	Occurrence of major postpartum hemorrhage (\>1000 ml)

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06033131/registered

API reference For AI assistants

Registered outcomes55

Sources 3

Read this list from software.